Antimicrobial breakpoint estimation accounting for variability in pharmacokinetics.

about

Pharmacokinetics of a peroral single dose of two long-acting formulations and an aqueous formulation of doxycycline hyclate in horses Biocides--resistance, cross-resistance mechanisms and assessment.

P2860

Q36716284-9BBEBD04-6B0C-4153-8CAC-EF26DCE964B7 Q38065203-ABAB3EA1-9CE4-4C45-9DCA-D478095900BA

P2860

Antimicrobial breakpoint estimation accounting for variability in pharmacokinetics.

Item

http://www.wikidata.org/entity/Q42040822

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Antimicrobial breakpoint estimation accounting for variability in pharmacokinetics.

@en

Antimicrobial breakpoint estimation accounting for variability in pharmacokinetics.

@nl

type

Item

label

Antimicrobial breakpoint estimation accounting for variability in pharmacokinetics.

@en

Antimicrobial breakpoint estimation accounting for variability in pharmacokinetics.

@nl

prefLabel

Antimicrobial breakpoint estimation accounting for variability in pharmacokinetics.

@en

Antimicrobial breakpoint estimation accounting for variability in pharmacokinetics.

@nl

P1476

Antimicrobial breakpoint estimation accounting for variability in pharmacokinetics.

@en

P2093

Fahima Nekka

http://www.w3.org/2001/XMLSchema#string

Goue Denis Gohore Bi

http://www.w3.org/2001/XMLSchema#string

Jun Li

http://www.w3.org/2001/XMLSchema#string

P2860

Forecasting individual pharmacokinetics

Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines

Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests.

Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint

Pharmacokinetic/pharmacodynamic modeling in drug development.

What do we really know about antibiotic pharmacodynamics?

Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters.

The population dynamics of antimicrobial chemotherapy.

How can we predict bacterial eradication?

Pharmacological indices in antibiotic therapy.

P2888

1742-4682-6-10

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-4682-6-10

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26322923

http://www.w3.org/2001/XMLSchema#string

P6179

1042525486

http://www.w3.org/2001/XMLSchema#string

P698

19558679

http://www.w3.org/2001/XMLSchema#string

P932

2709609

http://www.w3.org/2001/XMLSchema#string

Antimicrobial breakpoint estimation accounting for variability in pharmacokinetics.

about

P2860

P2860

Antimicrobial breakpoint estimation accounting for variability in pharmacokinetics.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932